Mehran, L. et al. Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study. Arch. Dis. Child. Fetal Neonatal Ed. 104, F176–F181 (2019).
Deladoey, J., Ruel, J., Giguere, Y. & Van Vliet, G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Quebec. J. Clin. Endocrinol. Metab. 96, 2422–2429 (2011).
Canaris, G. J., Steiner, J. F. & Ridgway, E. C. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J. Gen. Intern. Med. 12, 544–550 (1997).
CAS PubMed PubMed Central Google Scholar
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T. & Giovannucci, E. L. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA 314, 1818–1831 (2015).
CAS PubMed PubMed Central Google Scholar
ClinCalc DrugStats Database. Levothyroxine: Drug Usage Statistics, U. S., 2013–2019. ClinCalc.com https://clincalc.com/DrugStats/Drugs/Levothyroxine (2021).
Brito, J. P. et al. Levothyroxine use in the United States, 2008-2018. JAMA Intern. Med. 181, 1402–1405 (2021).
Jonklaas, J. et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–1751 (2014).
PubMed PubMed Central Google Scholar
Hollowell, J. G. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002).
Canaris, G. J., Manowitz, N. R., Mayor, G. & Ridgway, E. C. The Colorado Thyroid Disease Prevalence study. Arch. Intern. Med. 160, 526–534 (2000).
Garmendia Madariaga, A., Santos Palacios, S., Guillen-Grima, F. & Galofre, J. C. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 923–931 (2014).
Zimmermann, M. B. & Boelaert, K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 3, 286–295 (2015).
Pedersen, I. B. et al. A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin. Endocrinol. 75, 120–126 (2011).
Teumer, A. et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat. Commun. 9, 4455 (2018).
PubMed PubMed Central Google Scholar
Vanderpump, M. P. The epidemiology of thyroid disease. Br. Med. Bull. 99, 39–51 (2011).
Belin, R. M., Astor, B. C., Powe, N. R. & Ladenson, P. W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 89, 6077–6086 (2004).
Chaker, L. et al. Thyroid function characteristics and determinants: the rotterdam study. Thyroid 26, 1195–1204 (2016).
Kus, A. et al. Variation in normal range thyroid function affects serum cholesterol levels, blood pressure, and type 2 diabetes risk: a mendelian randomization study. Thyroid 31, 721–731 (2021).
Wang, X. et al. Causal association between serum thyrotropin and obesity: a bidirectional, mendelian randomization study. J. Clin. Endocrinol. Metab. 106, e4251–e4259 (2021).
PubMed PubMed Central Google Scholar
Liu, C. et al. Small for gestational age is a risk factor for thyroid dysfunction in preterm newborns. BMC Pediatr. 20, 179 (2020).
CAS PubMed PubMed Central Google Scholar
Asakura, Y., Tachibana, K., Adachi, M., Suwa, S. & Yamagami, Y. Hypothalamo-pituitary hypothyroidism detected by neonatal screening for congenital hypothyroidism using measurement of thyroid-stimulating hormone and thyroxine. Acta Paediatr. 91, 172–177 (2002).
Kempers, M. J. et al. Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J. Clin. Endocrinol. Metab. 91, 3370–3376 (2006).
Wright, J. J., Powers, A. C. & Johnson, D. B. Endocrine toxicities of immune checkpoint inhibitors. Nat. Rev. Endocrinol. 17, 389–399 (2021).
CAS PubMed PubMed Central Google Scholar
Maynard, M. A. et al. Thyroid hormone inactivation in gastrointestinal stromal tumors. N. Engl. J. Med. 370, 1327–1334 (2014).
CAS PubMed PubMed Central Google Scholar
Fekete, C. & Lechan, R. M. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr. Rev. 35, 159–194 (2014).
Brabant, G. et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J. Clin. Endocrinol. Metab. 70, 403–409 (1990).
Kopp, P. in Werner & Ingbar’s the Thyroid: A Fundamental and Clinical Text Ch. 6, 97–126 (Wolters Kluwer, 2021).
Schweizer, U., Johannes, J., Bayer, D. & Braun, D. Structure and function of thyroid hormone plasma membrane transporters. Eur. Thyroid J. 3, 143–153 (2014).
CAS PubMed PubMed Central Google Scholar
Ortiga-Carvalho, T. M., Sidhaye, A. R. & Wondisford, F. E. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat. Rev. Endocrinol. 10, 582–591 (2014).
CAS PubMed PubMed Central Google Scholar
Peeters, R. P., van der Deure, W. M. & Visser, T. J. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur. J. Endocrinol. 155, 655–662 (2006).
Drigo, R. A. & Bianco, A. C. Type 2 deiodinase at the crossroads of thyroid hormone action. Int. J. Biochem. Cell Biol. 43, 1432–1441 (2011).
Schweizer, U. & Steegborn, C. New insights into the structure and mechanism of iodothyronine deiodinases. J. Mol. Endocrinol. 55, R37–R52 (2015).
Merrill, S. J. & Minucci, S. B. Thyroid autoimmunity: an interplay of factors. Vitam. Hormones 106, 129–145 (2018).
Glinoer, D., Riahi, M., Grün, J.-P. & Kinthaert, J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J. Clin. Endocrinol. Metab. 79, 197–204 (1994).
Alexander, E. K. et al. 2017 Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27, 315–389 (2017).
Nazarpour, S., Tehrani, F. R., Amiri, M., Yarandi, R. B. & Azizi, F. Levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 300, 805–819 (2019).
Derakhshan, A. et al. The association of maternal thyroid autoimmunity during pregnancy with child IQ. J. Clin. Endocrinol. Metab. 103, 3729–3736 (2018).
Theofilopoulos, A. N., Kono, D. H. & Baccala, R. The multiple pathways to autoimmunity. Nat. Immunol. 18, 716–724 (2017).
CAS PubMed PubMed Central Google Scholar
Rapoport, B. & McLachlan, S. M. Reflections on thyroid autoimmunity: a personal overview from the past into the future. Horm. Metab. Res. 50, 840–852 (2018).
Wu, F. et al. Decreased β-catenin expression contributes to IFNγ-induced chemokine secretion and lymphocyte infiltration in Hashimoto’s thyroiditis. Endocr. Connect. 11, e210451 (2022).
CAS PubMed PubMed Central Google Scholar
Azizi, F. et al. Impairment of neuromotor and cognitive development in iodine-deficient schoolchildren with normal physical growth. Eur. J. Endocrinol. 129, 501–504 (1993).
Wolff, J. et al. The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid. Endocrinology 45, 504–513 (1949).
Leung, A. M. & Braverman, L. E. Iodine-induced thyroid dysfunction. Curr. Opin. Endocrinol. Diabetes Obes. 19, 414 (2012).
CAS PubMed PubMed Central Google Scholar
Rayman, M. P. Selenium and human health. Lancet 379, 1256–1268 (2012).
Wu, Q. et al. Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab. 100, 4037–4047 (2015).
Aung, E. T. et al. Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis. Clin. Endocrinol. 90, 192–199 (2019).
Kahraman, D. et al. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. Clin. Endocrinol. 76, 297–303 (2012).
Bonnema, S. J. et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J. Clin. Endocrinol. Metab. 84, 3636–3641 (1999).
留言 (0)